Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Tempest Therapeutics, Inc. (OVAS) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/03/2018 BW OvaScience Reports First Quarter 2018 Financial Results and Provides Business Update
03/15/2018 BW OvaScience Reports Fourth Quarter and Year-End 2017 Financial Results
03/08/2018 BW OvaScience to Host Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call
01/05/2018 GN SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against OvaScience, Inc. (OVAS) & Lead Plaintiff Deadline – January 22, 2018
12/19/2017 GN IMPORTANT OVASCIENCE, INC. INVESTOR REMINDER: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of investors who purchased and suffered losses in OvaScience, Inc.
11/30/2017 GN IMPORTANT OVASCIENCE, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of investors who purchased and suffered losses in OvaScience, Inc.
11/22/2017 GN OVASCIENCE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In OvaScience, Inc. To Contact The Firm
11/02/2017 BW OvaScience Reports Third Quarter 2017 Financial Results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy